000			02160 a2200577 4500
005			20250514191344.0
264		0	_c20050111
008			200501s 0 0 eng d
022			_a0167-0115
024	7		_a10.1016/j.regpep.2004.03.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aDe Souza, A M
245	0	0	_aAngiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor. _h[electronic resource]
260			_bRegulatory peptides _cAug 2004
300			_a167-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xpharmacology
650	0	4	_aAngiotensin I _xpharmacology
650	0	4	_aAngiotensin II _xanalogs & derivatives
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xpharmacology
650	0	4	_aAngiotensin II Type 2 Receptor Blockers
650	0	4	_aAnimals
650	0	4	_aAntihypertensive Agents _xpharmacology
650	0	4	_aCholera Toxin _xpharmacology
650	0	4	_aCyclic AMP _xmetabolism
650	0	4	_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors
650	0	4	_aGTP-Binding Proteins _xmetabolism
650	0	4	_aGuanosine Diphosphate _xmetabolism
650	0	4	_aGuanosine Triphosphate _xmetabolism
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aKidney Cortex _xdrug effects
650	0	4	_aLosartan _xpharmacology
650	0	4	_aPeptide Fragments _xpharmacology
650	0	4	_aPertussis Toxin _xpharmacology
650	0	4	_aPyridines _xpharmacology
650	0	4	_aReceptor, Angiotensin, Type 2 _xagonists
650	0	4	_aSodium-Potassium-Exchanging ATPase _xmetabolism
650	0	4	_aSwine
650	0	4	_aVasoconstrictor Agents _xpharmacology
700	1		_aLopes, A G
700	1		_aPizzino, C P
700	1		_aFossari, R N
700	1		_aMiguel, N C O
700	1		_aCardozo, F P
700	1		_aAbi-Abib, R
700	1		_aFernandes, M S
700	1		_aSantos, D P A
700	1		_aCaruso-Neves, C
773	0		_tRegulatory peptides _gvol. 120 _gno. 1-3 _gp. 167-75
856	4	0	_uhttps://doi.org/10.1016/j.regpep.2004.03.005 _zAvailable from publisher's website
999			_c14885468 _d14885468